OPC Pharmaceutical Joint Stock Company (HOSE: OPC)
Health Care · Pharmaceuticals · VN
₫21,000.00
-0.94% today · +9.2% 1Y
OPC Pharmaceutical Joint Stock Company (HOSE: OPC) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $60.25M.
Over the last twelve months the share price has gained 9.2%, trading between 18.03K and 22.60K.
Tweenvest scores OPC Pharmaceutical Joint Stock Company across four factors: quality 81/100, value 49/100, growth 35/100, dividend 76/100. Its strongest factor is quality.
OPC price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $60.25M
- Revenue (TTM)
- $43.83M
- P/E
- 15.55
- EPS
- 1,350.18
- Dividend yield
- 3.26%
- Beta (5Y)
- 0.10
- 52-week high
- ₫22,600.00
- 52-week low
- ₫18,034.19
- Avg volume (3M)
- —
- Shares outstanding
- 74.94M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.11T | $1,247.70 | +0.06% |
| Johnson & JohnsonNYSE: JNJ | $658.00B | $271.02 | -0.74% |
| Merck & Co., Inc.NYSE: MRK | $371.70B | $151.20 | +0.36% |
| Roche Holding AGSWX: ROP | $368.80B | CHF371.10 | +0.19% |
| Novartis AGSWX: NOVN | $300.52B | CHF126.76 | -0.52% |
| AstraZeneca PLCLSE: AZN | $256.25B | £121.32 | +0.18% |
| Novo Nordisk A/SCPSE: NOVO B | $206.64B | Dkr299.25 | -0.53% |
| Pfizer Inc.NYSE: PFE | $159.42B | $28.02 | +0.18% |
Figures last refreshed Aug 18, 2026.